Medley Pharma up for sale, expected to be sold for Rs 5,000 crore Susmita Roy26 May 2022 11:06 AM ISTNew Delhi: Medley Pharma, a privately held Mumbai-based pharmaceutical company, is up for sale and is expected to be sold for Rs 5,000 crore in a...
Pharma company Dr. Reddy's plans business continuity in Russia MD Bureau10 March 2022 5:09 PM ISTThe company said in its annual report last year that its focus was on "scaling up in our major markets, which include Russia, China, Brazil, South...
India to become hub for Covid-19 antiviral generic drugs: Fitch Medical Dialogues Bureau8 Jan 2022 3:03 PM ISTNew Delhi: India will become the largest global hub for Covid-19 antiviral general drug production after the drug controller granted emergency-use...
Dr Reddys to launch anti-COVID drug Molnupiravir under brand name Molflu at Rs 35 per capsule Medical Dialogues Bureau5 Jan 2022 3:53 PM IST"Molflu (Molnupiravir) is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high...
40 pharma firms interested in producing anti COVID drug 2-DG: DRDO tells Madras HC Ruchika Sharma26 Jun 2021 12:12 PM ISTChennai: The Madras High Court was told by the Defence Research and Development Organisation (DRDO) on Friday that 40 pharmaceutical firms had shown...
DRDO invites Indian pharma firms for bulk production of COVID drug 2DG Medical Dialogues Team10 Jun 2021 6:26 PM ISTNew Delhi: The Defence Research and Development Organisation (DRDO) has called for an Expression of Interest (EoI) for Transfer of Technology (ToT)...
BMC in talks with Dr Reddys after rejecting all 9 vaccine supply bids Medical Dialogues Team7 Jun 2021 10:15 AM ISTMumbai: After rejecting all nine bids from facilitator firms for procurement of 1 crore Covid-19 vaccine doses for Mumbai due to insufficient...
Dr Reddys warns against bogus Sputnik V suppliers in India Medical Dialogues Team30 May 2021 10:00 AM ISTHyderabad: With the aim of making consumers aware of unauthorised individuals selling false deals or procurements of the Sputnik V vaccine, Dr Reddy's...
Merck inks licensing pact with Cipla, Sun Pharma, 3 others for oral COVID drug Molnupiravir Medical Dialogues Team28 April 2021 11:51 AM ISTMumbai: In order to accelerate and expand global access to Molnupiravir for treating Covid-19, Merck (known as MSD Pharmaceuticals outside the United...
Dr Reddys working on Sputnik V stability data on 2 to 8 C temperature range Ruchika Sharma15 April 2021 12:48 PM ISTNew Delhi: Dr Reddy's Laboratories is in the process of generating additional stability data for Russia's COVID-19 vaccine Sputnik V, which has a...
Submit more data on Sputnik V: CDSCO panel to Dr Reddys Medical Dialogues Team11 April 2021 11:15 AM ISTNew Delhi: In response to an application for emergency use authorization of Russian Covid-19 vaccine Sputnik V, the Subject Expert Committee (SEC)...
Sun Pharma, Dr Reddys, others eyeing to buy Oaknet Healthcare: Report Medical Dialogues Team16 March 2021 9:00 AM ISTMumbai: The leading pharmaceutical companies including Sun Pharmaceutical, Dr Reddy's Labs (DRL), JB Chemicals & Pharmaceuticals, Torrent Pharma,...
